CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Orchard Therapeutics plc

ORTX
N/A

Next catalyst

No upcoming catalyst in our data

No upcoming FDA decision, filing or trial readout is on file for ORTX. That does not mean none is planned.

Get an email about ORTX's next catalysts

Track Orchard Therapeutics (ORTX) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Catalyst Timeline

0 upcoming, 0 past

No catalysts found.

Market Overview

Stock performance and key metrics

NASDAQGene TherapyπŸ‡ΊπŸ‡ΈNorth America

Frequently asked questions

What is in Orchard Therapeutics plc's drug pipeline?β†’

CatalystAlert tracks 4 drug candidates in Orchard Therapeutics plc's (ORTX) pipeline across Phase 2. Its lead program is Autologous CD34+ cells transduced with a lentiviral vector containing the human SGSH gene (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is Orchard Therapeutics plc's next FDA catalyst?β†’

CatalystAlert tracks every upcoming catalyst for Orchard Therapeutics plc (ORTX) β€” PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β€” each confidence-rated as confirmed, estimated or AI-detected.

How do I track ORTX biotech catalysts?β†’

Add ORTX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Orchard Therapeutics plc's live catalyst calendar, drug pipeline and clinical-trial timeline on this page β€” sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply